» Articles » PMID: 189684

Inactivation of Lipid-containing Viruses by Long-chain Alcohols

Overview
Specialty Pharmacology
Date 1977 Jan 1
PMID 189684
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

This report describes the inactivation of lipid-containing viruses by several long-chain alcohols. A striking peak in antiviral activity was found for saturated alcohols having chain lengths from 10 to 14 carbons. Viruses having different membrane structure showed different susceptibilities to alcohols having different chain lengths and structural features. Decanol, dodecanol, and tetradecanol readily inactivated herpes simplex virus and the enveloped bacterial virus phi6. The lipid-containing virus PM2 was susceptible to decanol and dodecanol but comparatively unsusceptible to tetradecanol. The branched-chain alcohol phytol, a naturally occurring component of chlorophyll, was active against phi6 and herpes simplex virus but not against PM2. Polyoma virus and the bacteriophage phi23-1-a, which do not contain lipids, were not susceptible to inactivation by any of the alcohols tested. Experiments were also carried out to determine the effects of these compounds on cells. At 0.5 mM, decanol lysed human embryonic lung cells, erythrocytes, and the bacterial hosts for phi6 and PM2. Dodecanol, tetradecanol, and phytol at this concentration were less damaging to cells. At 0.05 mM, none of the alcohols caused observable cytopathic effects on human embryonic lung cells, although several of the alcohols at this concentration were active against herpes simplex virus. Our findings suggest that dodecanol, tetradecanol, and phytol may warrant further studies as potential antiviral agents, particularly for topical application to virus-infected areas of the skin.

Citing Articles

Study on molecular mechanism of volatiles variation during root development based on metabolome and transcriptome analysis.

Yu D, Wang W, Huo J, Zhuang Y, Chen Y, Du X Front Plant Sci. 2023; 14:1159511.

PMID: 37035038 PMC: 10079991. DOI: 10.3389/fpls.2023.1159511.


Therapeutic efficacy of -Docosanol against velogenic Newcastle disease virus infection in domestic chickens.

Orabi A, Hussein A, Saleh A, Megahed A, Metwally M, Moeini H Front Microbiol. 2022; 13:1049037.

PMID: 36483200 PMC: 9724783. DOI: 10.3389/fmicb.2022.1049037.


Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro.

Raghavan P Biomed Res Int. 2022; 2022:1558860.

PMID: 35039793 PMC: 8760534. DOI: 10.1155/2022/1558860.


How were new medicines discovered?.

Swinney D, Anthony J Nat Rev Drug Discov. 2011; 10(7):507-19.

PMID: 21701501 DOI: 10.1038/nrd3480.


Characteristics of a new bacteriophage, Psp231a, infecting Pseudomonas phaseolicola HB10Y.

Taylor W, Deluca N, Vollherbst K, Doman T, DAmato T, SNIPES W J Virol. 1980; 35(3):918-23.

PMID: 7420544 PMC: 288885. DOI: 10.1128/JVI.35.3.918-923.1980.


References
1.
SNIPES W, Person S, Keith A, Cupp J . Butylated hydroxytoluene inactivated lipid-containing viruses. Science. 1975; 188(4183):64-6. DOI: 10.1126/science.163494. View

2.
Person S, Knowles R, Read G, Warner S, Bond V . Kinetics of cell fusion induced by a syncytia-producing mutant of herpes simplex virus type I. J Virol. 1975; 17(1):183-90. PMC: 515402. DOI: 10.1128/JVI.17.1.183-190.1976. View

3.
Knowles R, Person S . Effects of 2-deoxyglucose, glucosamine, and mannose on cell fusion and the glycoproteins of herpes simplex virus. J Virol. 1976; 18(2):644-51. PMC: 515591. DOI: 10.1128/JVI.18.2.644-651.1976. View

4.
Wanda P, Cupp J, SNIPES W, Deith A, Rucinsky T, Polish L . Inactivation of the enveloped bacteriophage phi6 by butylated hydroxytoluene and butylated hydroxyanisole. Antimicrob Agents Chemother. 1976; 10(1):96-101. PMC: 429695. DOI: 10.1128/AAC.10.1.96. View

5.
Cupp J, Wanda P, Keith A, SNIPES W . Inactivation of the lipid-containing bacteriophage PM2 by butylate hydroxytoluene. Antimicrob Agents Chemother. 1975; 8(6):698-706. PMC: 429451. DOI: 10.1128/AAC.8.6.698. View